Nyumbani › COPD › Texas › Dallas
Majaribio ya kliniki ya COPD katika Dallas, TX
Masomo 12 ya COPD yanatafuta washiriki katika vituo vya Dallas na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
InaajiriHatua 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
InaajiriHatua 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
InaajiriHatua 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Inaajiri
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
InaajiriHatua 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
InaajiriHatua 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
InaajiriHatua 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
InaajiriHatua 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
InaajiriUtafiti wa uchunguzi
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
InaajiriHatua 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
InaajiriUtafiti wa uchunguzi
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
InaajiriHatua 3
- GSK Investigational Site, Dallas
Majaribio ya COPD katika miji mingine
- Philadelphia, PAUtafiti 23
- Miami, FLUtafiti 18
- Birmingham, ALUtafiti 17
- Boston, MAUtafiti 17
- Houston, TXUtafiti 15
- Orlando, FLUtafiti 15
- Baltimore, MDUtafiti 14
- Chicago, ILUtafiti 14
- Pittsburgh, PAUtafiti 12
- New York City, NYUtafiti 11
- Ann Arbor, MIUtafiti 10
- Detroit, MIUtafiti 9
Masomo mengine katika Dallas
- Saratani ya MatitiUtafiti 55
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 52
- Saratani ya MetastasiUtafiti 42
- Kushindwa kwa MoyoUtafiti 42
- Saratani (aina zote)Utafiti 37
- Saratani ya ProstateUtafiti 36
- Kansari ya kolorektaliUtafiti 33
- UnenepuUtafiti 30
- Kansari ya MayaiUtafiti 28
- Saratani ya MkojoUtafiti 27
- Saratan ya MapafuUtafiti 27
- Saratani ya EndometrialUtafiti 24
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.